- Home
- UHAL vs BSX Comparison
UHAL vs BSX Comparison
Compare UHAL & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UHAL | BSX |
|---|---|---|
| Founded | 1945 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Rental/Leasing Companies | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 137.8B |
| IPO Year | N/A | 1992 |
Fundamental Metrics
Financial Performance| Metric | UHAL | BSX |
|---|---|---|
| Price | $50.79 | $95.59 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 17 |
| Target Price | N/A | ★ $125.88 |
| AVG Volume (30 Days) | 167.5K | ★ 9.5M |
| Earning Date | 02-04-2026 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 54.68 |
| EPS | 1.19 | ★ 1.87 |
| Revenue | $5,972,459,000.00 | ★ $19,349,000,000.00 |
| Revenue This Year | $6.61 | $21.05 |
| Revenue Next Year | $4.20 | $11.44 |
| P/E Ratio | ★ $42.85 | $51.34 |
| Revenue Growth | 5.86 | ★ 21.61 |
| 52 Week Low | $48.48 | $85.98 |
| 52 Week High | $75.19 | $109.50 |
Technical Indicators
Market Signals| Indicator | UHAL | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 39.46 | 46.31 |
| Support Level | $50.45 | $95.55 |
| Resistance Level | $51.81 | $96.64 |
| Average True Range (ATR) | 1.04 | 1.50 |
| MACD | -0.18 | 0.33 |
| Stochastic Oscillator | 0.10 | 75.18 |
Price Performance
Historical ComparisonAbout UHAL U-Haul Holding Company
U-Haul Holding Co is an American moving truck, trailer, and self-storage rental company. The company also provides moving boxes, packing supplies, LPG (propane) refills, trailer hitch and wiring installation, storage container rentals, and other services. It has three reportable segments Moving and Storage, Property and Casualty Insurance, and Life Insurance. The majority of its revenue comes from the Moving and Storage segment.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.